DISCOUNT ZERTIFIKAT - CVS HEALTH Share Price

Certificat

DE000PC63J38

Real-time Boerse Frankfurt Warrants 05:50:35 27/06/2024 pm IST
50.89 EUR -2.90% Intraday chart for DISCOUNT ZERTIFIKAT - CVS HEALTH
Current month+4.11%
1 month+10.50%
Date Price Change
27/24/27 50.89 -2.90%
26/24/26 52.41 -0.10%
25/24/25 52.46 -1.39%
24/24/24 53.2 +0.04%
21/24/21 53.18 +0.80%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 05:50 pm IST

More quotes

Static data

Product typeCertificados de Descuento
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC63J3
ISINDE000PC63J38
Date issued 22/03/2024
Maturity 19/12/2025 (540 Days)
Parity 1 : 1
Emission price 64.62
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 66.88
Lowest since issue 45.21
Spread 0.25
Spread %0.49%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus